6.9K
Downloads
23
Episodes
Very welcome to Theragnostic Talks by SAM Nordic, the only podcast about theragnostics. What are even theragnostics? And what does the future for it look like? In this podcast, we learn about new science and get answers to curious questions by talking with the experts in the field - clinicians, scientists, and people from the industry. To guide us through the episodes are Gustav Widar. Gustav has a background as a licensed medical physicist and has worked many years in the field of nuclear medicine – covering imaging, therapy, and the production of radiopharmaceuticals. He is driven by making medical innovations a clinical reality – where it benefits patient care. A couple of years ago he changed from healthcare to industry, now Medical Affairs Manager at SAM Nordic. This is a podcast for Health Care Professionals.
Episodes
Wednesday Jun 23, 2021
Wednesday Jun 23, 2021
We gathered up with Oliver Sartor, Bernd Krause and Ken Hermann, co-authors of the VISION study, to talk about how it will impact the treatment of prostate cancer. The VISION study is the first international randomized open label phase III study that shows convincing results for a novel treatment of late-stage advanced prostate cancer. A targeted treatment for prostate cancer using radioactive 177Lu-PSMA-617. Successful? Without a doubt if you ask Oliver Sartor.
– This is the theragnostic breakthrough we all have been waiting for. It's going to change the way we treat cancer.
Join us on Theragnostic Talks!
Guest: Oliver Sartor, Bernd Krause, Ken Hermann
By: Gustav Widar
Contact us: podcast@samnordic.se
For more info, visit www.samnordic.se
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.